Methyl 3-chloro-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate

Catalog No. :
ACMJWE867
CAS No. :
2639387-25-8
Molecular Formula :
C15H20BClO4
Molecular Weight :
310.59

IUPAC Name:methyl 3-chloro-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate

Methyl 3-chloro-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$219.00Login to see priceInquiryInquiry
100mg95%$318.00Login to see priceInquiryInquiry
250mg95%$451.00Login to see priceInquiryInquiry
1g95%$890.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-chloro-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
IUPAC Namemethyl 3-chloro-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
Molecular FormulaC15H20BClO4
Molecular Weight310.59
SMILESO=C(C1=CC(B2OC(C)(C(C)(O2)C)C)=C(C(Cl)=C1)C)OC
InChI KeyUJTBXBAXEWDBLR-UHFFFAOYSA-N
SynonymBenzoic acid, 3-chloro-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, methyl ester;Methyl 3-chloro-4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
CAS No.2639387-25-8

Synthetic Route by SureRoute

1. ACMJWE867 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMJWE867 route product structure diagram
    ACMJWE8672639387-25-8
Inquiry

2. ACMJWE867 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACCZOQ592 route compound structure diagram
    ACCZOQ59221324-01-6 In Stock
  4. Then
  5. ACMJWE867 route product structure diagram
    ACMJWE8672639387-25-8
Inquiry

Comments (0)